ADAPTIVE BIOTECHNOLOGIES CORPORATION Income (Loss) from Continuing Operations before Income Taxes, Domestic
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$59.47 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-26
- ADAPTIVE BIOTECHNOLOGIES CORPORATION income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$59.47M.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$159.63M.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$225.34M.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$200.43M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$59.47M 10-K · filed 2026-02-26 |
| 2024-12-31 | -$159.63M 10-K · filed 2026-02-26 |
| 2023-12-31 | -$225.34M 10-K · filed 2026-02-26 |
| 2022-12-31 | -$200.43M 10-K · filed 2025-03-03 |
| 2021-12-31 | -$207.31M 10-K · filed 2024-02-29 |
| 2020-12-31 | -$146.23M 10-K · filed 2023-02-14 |
| 2019-12-31 | -$68.61M 10-K · filed 2022-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |